The fight against medicines of doubtful origin continues in poor countries

It is common for persons trust blindly when ingesting medicines, but this is usually more reliable only in the cases of those countries that belong to the First world.

a study made by the United Nations (HIM-HER-IT) determined that a 10% of the medicine sold in Developing countries sound of low quality it is included fakes. That is why the importance of improving the detection system and control regarding the sale of drugs.

Identification of medications original can be found in the container, which is unique, a factor that prevents the entry of possible counterfeits into the legal supply chain. In this way it is unlikely that a medicine adulterated or risk reaches the hands of the population.

Two exists key tools to detect those products that have been altered. The first is a identifier with a two-dimensional verification code It contains twenty randomly generated characters, plus the package bears the batch number and expiration date. The second is a anti-tampering system that guarantees that the container has not been opened from when it is produced until it is sold in the establishments of medical supplies.

These methods have been effective thanks to the joint work of marketers, dealers, pharmacy and private hospitals. In this way it was recorded that 2.7 billion of drugs had unique identifiers, more than 750 million of containers had been verified and more than 500 million of drugs were taken off the market for their irregularities.

Thanks to the digitization, the identification system can track all stages of the evolution of the drug, that is, they are two large allies that work perfectly to avoid serious consequences.

Despite the state standards and international organizations, there are Business who are dedicated to developing tools to further improve the detection of frauds. One of them is SICPA, a swiss company that created a label that allows to determine the copies by identifying the plastics used for the medical devices.

According to the Swiss company, these false drugs are responsible for 700.000 people die from malaria and the tuberculosis.

And in time of pandemic, counterfeits have reached both diagnostic tests like to European Digital Covid Certificate. For this reason, SICPA confesses that currently these procedures are more necessary than ever, when on these two tools depends the spread of coronavirus.

“We are advising Governments and authorities to prevent the falsification of the passport and coronavirus tests “said the director of Business Development of SICPA. He also added that” they should be implemented robust measures to avoid these scams. “


The post The fight against medicines of doubtful origin continues in poor countries appeared first on Archyde.

Source link

Leave a Comment